TGA · AHPRA · FSANZ · ACCC · Last reviewed: November 2026

    AdCheck and CompliGUARD: how ad approval and pre-publication review work together (Australia, 2026)

    20 November 2026 · 5 min read
    Summary

    AdCheck and CompliGUARD do different jobs, and health brands that run paid campaigns need both. AdCheck issues the approval number many retailers and publishers require before an ad can run. CompliGUARD reviews the whole piece against four frameworks before it is submitted, so it reaches AdCheck already clean and clears in one round instead of several — and it covers the social, EDM and product-page content that sits outside AdCheck's scope. The two are complementary, not alternatives.

    Most health-brand marketers have lived this sequence. The campaign is built, the assets are signed off internally, and the only thing left is the final approval before launch. It is meant to be the easy part. Then the first set of changes comes back. The copy is adjusted and resubmitted. A second approval is required for a different channel, and it bounces the same asset for a different reason. The change that satisfied one reviewer unsettles the other. Around it goes — and each loop burns creative time and pushes the launch date back. The campaign was planned to land at the peak of a seasonal window. It lands after it.

    This is rarely a failure of the approval services themselves. It is a structural problem with when and how review happens: near-final assets, reviewed in series, by separate services that do not share a determination, with a fee attached to each revision. The cost is not a fine. It is the launch that shipped late, the media money spent against a window that had already closed, and the hours a creative team spent on rounds instead of on the next campaign. That is the quiet tax on marketing velocity, and it is exactly the loss worth removing.

    What AdCheck does — and why its number still matters

    AdCheck, run by CHP Australia, reviews advertising for therapeutic goods against the Therapeutic Goods Advertising Code and issues an approval reference for the finished ad. In law, pre-publication review has been voluntary since industry pre-approval ended on 1 July 2020 — advertisers are responsible for their own compliance. In practice, an AdCheck number is not optional for everyone: major retailers, including pharmacy catalogue and website advertising, require one before they will run a brand's ad. For those channels, the number is a commercial gate. CompliGUARD does not change that and does not try to. Where an AdCheck number is required, it stays required.

    Where the delay actually comes from

    The friction is in the sequence, not the verdict. Three things drive it:

    • Review happens late. The asset is already near-final when it reaches approval, so every flag means reworking finished creative, not an early draft.
    • Separate services review in series. When a second mandatory sign-off sits alongside AdCheck — a broadcaster's clearance, a retailer's own approval — the same asset is reviewed twice against different priorities, and a change made for one can reopen the other.
    • Revisions are billed and repeated. Each round is a fresh submission with its own turnaround and, often, its own fee. Two or three rounds is common, and the calendar does not wait.

    None of this says the reviewer is wrong. It says the brand arrived at the gate carrying problems it could have cleared earlier.

    How a readiness layer changes the sequence

    The fix is to move the review forward — to make the asset compliant before it is submitted, so the mandatory approval becomes a confirmation rather than a negotiation. That means reviewing the whole piece, not isolated phrases. The TGA Advertising Code, like the AHPRA, FSANZ and ACCC frameworks, assesses the overall impression a reasonable person takes from the complete ad — headline, image, product reference and implied benefit together — not a single line in isolation. A readiness check has to read content the same way, across every framework that applies to the piece, and name the specific rule behind each flag so the fix is precise.

    Get that right and the asset that reaches AdCheck is already clean. One round, not five. The creative team spends its time on the work, not on the rounds. And the campaign lands inside its window.

    What AdCheck doesn't reach

    AdCheck reviews the ad. Modern health marketing is far more than the ad. A single launch now runs across EDMs, organic and paid social, influencer briefs, blog content and product pages — much of it published weekly, at a pace no per-ad review was built for. These channels carry the same TGA, and often FSANZ and ACCC, obligations as the catalogue ad, but they rarely pass through AdCheck at all. This is the gap: the content that goes live fastest is the content least likely to have been reviewed. A brand can hold a clean AdCheck number for its catalogue ad and still publish a non-compliant claim in an EDM the same afternoon.

    How CompliGUARD automates this check

    CompliGUARD is compliance infrastructure that reviews marketing content against TGA · AHPRA · FSANZ · ACCC in minutes. It reads the whole piece the way a regulator does — overall impression, not keyword matching — checks claims against the product's registered indications, grades the risk as low, medium or high, cites the specific clause behind every flag, and offers a compliant rewrite that preserves the marketing intent. Every review is logged and timestamped in the Audit Vault as evidence of due diligence. Used before submission, it clears the content that goes to AdCheck so it passes first time; used across the campaign, it covers the social, EDM and product-page content AdCheck never sees. It sits alongside AdCheck, not in place of it.

    Key takeaways

    1. AdCheck and CompliGUARD do different jobs — brands running paid campaigns need both.
    2. An AdCheck number stays mandatory wherever a retailer or publisher requires it; CompliGUARD does not replace it.
    3. Most approval delay comes from reviewing near-final assets in series, not from the verdict.
    4. Reviewing the whole piece against four frameworks before submission is what turns several approval rounds into one.
    5. The content that goes live fastest — social, EDM, product pages — is what AdCheck doesn't review and CompliGUARD does.

    Regulatory references

    • Therapeutic Goods Act 1989 (Cth), Chapter 5 (advertising)
    • Therapeutic Goods (Advertising Code) Instrument 2021 — including s.19 mandatory statements for advertisements
    • Health Practitioner Regulation National Law, s.133 (advertising of regulated health services)
    • AHPRA, Guidelines for advertising a regulated health service, December 2020
    • FSANZ, Australia New Zealand Food Standards Code, Standard 1.2.7 (nutrition, health and related claims)
    • Australian Consumer Law (Competition and Consumer Act 2010, Sch 2), ss.18 and 29; ACCC Advertising and Selling Guide, July 2021

    CompliGUARD provides compliance and creative marketing insights based on TGA, FSANZ, ACCC and AHPRA guidance as current at the time of review. The Therapeutic Goods Advertising Code is currently under formal review by the TGA (2025–26). CompliGUARD assessments reflect the current Code; guidance may be subject to change. CompliGUARD is not affiliated with AdCheck or CHP Australia; trademarks belong to their owners. This output does not constitute legal advice.